{"id":"https://genegraph.clinicalgenome.org/r/a64da08d-9dd9-42c3-9c3a-3c27649b0e8fv1.0","type":"EvidenceStrengthAssertion","dc:description":"UPK3A was first reported in relation to autosomal dominant Congenital anomaly of the kidney and urinary tract (CAKUT) in 2005 (Jenkins et al., PMID: 15888565). At the time of curation, there were no single gene disorders associated with UPK3A. In the literature, UPK3A was implicated in the pathogenesis of CAKUT, Renal agenesis/Hypoplasia, and Vesicoureteral reflux (VUR). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference/difference in molecular mechanism and inheritance pattern, with CAKUT, VUR, and Renal agenesis/hypoplasia being representative of a CAKUT phenotypic spectrum. Therefore, the following disease entities have been lumped into one disease entity, CAKUT (MONDO:0019719).8 variants (missense,  nonsense, frameshift) that have been reported in 9 probands in publications (PMIDs:16731295 ,22558067, 26489027, 30773290, 32164334, 34979951, 36417404) are included in this curation. The majority of these variants were scored at 0 points due to all high frequencies in populations. This gene-disease association is also supported by an animal model and expression studies. In summary, the evidence supporting the relationship between UPK3A and autosomal dominant Congenital anomaly of the kidney and urinary tract has been disputed and no valid evidence remains to support the claim. More evidence is needed to either support or entirely refute the role. This classification was approved by the ClinGen CAKUT GCEP on the meeting date 1/9/23 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/a64da08d-9dd9-42c3-9c3a-3c27649b0e8f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/825a0eca-b652-43f4-a258-98cdd32751df","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/825a0eca-b652-43f4-a258-98cdd32751df_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10070","date":"2023-06-30T14:51:05.538Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/825a0eca-b652-43f4-a258-98cdd32751df_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10070","date":"2023-01-09T17:00:00.000Z","role":"Approver"}],"curationReasonDescription":"There is less than 1 point of genetic evidence scored. ","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/825a0eca-b652-43f4-a258-98cdd32751df_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8573a80a-6e2e-4d63-b108-b693462a593c","type":"EvidenceLine","dc:description":"Proband was also compound heterozygous for variants in FRAS1 wich confounds CAKUT phenotype (p.Tyr2273* from the father and p.Gly3456Asp from the mother)","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8573a80a-6e2e-4d63-b108-b693462a593c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32164334","allele":{"id":"https://genegraph.clinicalgenome.org/r/c1661575-8620-4ef4-8d44-9b240fda86ce","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006953.4(UPK3A):c.466_467del (p.Leu156ValfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10284387"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e38a8eeb-bc1c-4e5b-ac14-534548d00eaa","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e38a8eeb-bc1c-4e5b-ac14-534548d00eaa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34979951","allele":{"id":"https://genegraph.clinicalgenome.org/r/ef36e115-7dff-427d-a767-a0347534b94e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006953.4(UPK3A):c.167C>G (p.Thr56Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10284288"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/02b1d3b6-4687-4c72-9db6-cb1392b5b04c","type":"EvidenceLine","dc:description":"19/113526 alleles\nMAF 0.00167\nEuropean (non-Finish) population\n","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/02b1d3b6-4687-4c72-9db6-cb1392b5b04c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30773290","allele":{"id":"https://genegraph.clinicalgenome.org/r/e838b570-2b7a-42cd-8ca5-0ea0f9ac1e3b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006953.4(UPK3A):c.227C>A (p.Ser76Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10284328"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/fbedfb0a-8611-4e1e-b189-f5991cc6e867","type":"EvidenceLine","dc:description":"VUS. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fbedfb0a-8611-4e1e-b189-f5991cc6e867_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16731295","allele":{"id":"https://genegraph.clinicalgenome.org/r/322d2aa0-b236-48e3-a09f-40521adbc66c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006953.4(UPK3A):c.605G>A (p.Gly202Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA114597"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ff96c08e-f588-4647-8833-56bcf589692a","type":"EvidenceLine","dc:description":"19/113526 alleles (MAF 0.00167) in the European (non-Finish). \n","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff96c08e-f588-4647-8833-56bcf589692a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26489027","allele":{"id":"https://genegraph.clinicalgenome.org/r/e838b570-2b7a-42cd-8ca5-0ea0f9ac1e3b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0a39c63c-ac0c-4f2b-9ebf-a367252a1ede","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a39c63c-ac0c-4f2b-9ebf-a367252a1ede_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22558067","allele":{"id":"https://genegraph.clinicalgenome.org/r/1b771c4d-ee63-4f50-9523-6eff57e8907c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006953.4(UPK3A):c.811C>T (p.Arg271Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10284551"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/00882fa9-4ae1-47cb-a1ac-426d18a83837","type":"EvidenceLine","dc:description":"High MAF (0.002092); 269/128582 alleles in the European (non-Finnish) population. \n","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00882fa9-4ae1-47cb-a1ac-426d18a83837_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22558067","allele":{"id":"https://genegraph.clinicalgenome.org/r/535dfbd1-23b0-4cbb-ad15-bd0fca0e0e6d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006953.4(UPK3A):c.818C>T (p.Pro273Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA114594"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/b6735d1f-477b-42ea-975d-10c1f6ece151","type":"EvidenceLine","dc:description":"Variant is B/LP in ClinVar and has a high MAF; 684/24998 alleles (0.02736) in the European (Finnish) population. \n","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b6735d1f-477b-42ea-975d-10c1f6ece151_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36417404","allele":{"id":"https://genegraph.clinicalgenome.org/r/fede5b26-5900-465b-91af-9682d03d78bc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006953.4(UPK3A):c.545G>A (p.Trp182Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10284431"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/4d275af1-5cb9-499c-a1d3-bb019bb3dfbd","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d275af1-5cb9-499c-a1d3-bb019bb3dfbd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22558067","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fb86d3c-e053-4b21-8de0-16f5f8f812e9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006953.4(UPK3A):c.211A>G (p.Ile71Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA411877722"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/825a0eca-b652-43f4-a258-98cdd32751df_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/825a0eca-b652-43f4-a258-98cdd32751df_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b717a524-3f1a-424a-8209-9c7dfc763882","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/50e6a143-01f1-4d12-b2c8-46c7dfea1ed1","type":"Finding","dc:description":"Findings indicated that UPK3A is an integral subunit of the urothelial plaque and contributes to the permeability barrier function of the urothelium; Upk3 deficiency in mice can result in global anomalies of the urinary tract\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11085999","rdfs:label":"Hu_Mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/825a0eca-b652-43f4-a258-98cdd32751df_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1ec82f16-222b-4876-8d7d-8f9ffde86866","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9d75be53-d312-47c0-a442-701ad2b0534e","type":"Finding","dc:description":"A real-time RT-PCR for UPK3A mRNA of exfoliated urothelial cells from 18 primary VUR and 38 control samples. \n\nResearchers found that UPK3A mRNA was up-regulated to a greater extent in VUR than in control exfoliated urinary cells\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17880289","rdfs:label":"Iwaki_Expression","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7cfdf6b1-bf51-4b75-945a-34a4e9834c3f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5062e021-0f47-4e85-9721-3c705456b640","type":"Finding","dc:description":"Analysis of whole embryos at E9.5 and E10.5 and sections of E9.5 to E14.5 embryos showed:\n\nIn E9.5 and E10.5 embryos, researchers did not detect expression of Upk3a \nAt E12.5, they found weak neuronal expression in the central nervous system \nAt E14.5, the urothelium of the renal pelvis, the bladder and the ureter was positive for UPK3A expression as well as a subpopulation of alveolar epithelial cells and the olfactory epithelium\n\nAdditionally, In 6-month-old mice UPK3A expression was not detected in the epicardial layer of the heart but was found in the urothelium of the renal pelvis, the ureter and the bladder\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25389758","rdfs:label":"Rudat_Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d2560273-9603-4d25-bf97-a3083be32068","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e21054c-1a87-4f5d-956e-464e9db41c79","type":"Finding","dc:description":"At 7 wks gestation UPK3A was immunolocalized in the lumenal epithelial layer of the urogenital sinus \n \nAt 13 wk gestation, expression of UPK3A was maintained in the bladder urothelium;\nmesenchyme surrounding the ureter has not yet formed muscle bundles.\nUPK3A was expressed in urothelium of the ureters and the renal pelvis \n\n Expression of UPK3A always appeared apical consistent with the formation of urothelial plaques.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15888565","rdfs:label":"Jenkins_Immunohistochemistry","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5}],"evidenceStrength":"Disputed","sequence":6567,"specifiedBy":"GeneValidityCriteria9","strengthScore":4,"subject":{"id":"https://genegraph.clinicalgenome.org/r/aR3jdMV7rA4","type":"GeneValidityProposition","disease":"obo:MONDO_0019719","gene":"hgnc:12580","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_825a0eca-b652-43f4-a258-98cdd32751df-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}